NBP2262281
Novus Biologicals™ Imiquimod, TLR7 Ligand
Manufacturer: Novus Biologicals™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP2262281-Each-of-1 | In Stock | ₹ 16,135.70 |
NBP2262281 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 16,135.70
GST (18%): ₹ 2,904.426
Total Price: ₹ 19,040.126
Content And Storage
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For Use With (Application)
For activation of TLR7
Product Type
Imiquimod, TLR7 Ligand
Quantity
1 mg
Related Products
Description
- Imiquimod, TLR7 ligand is an imidazoquinoline amine analog to guanosine
- As a synthetic molecule of the Imidazoquinoline family, it has potent immunostimulatory activity
- Imiquimod has been shown to activate only TLR7, this activation is MyD88 dependant and leads to the induction of the transcription factor NF-kB
- Species: Human, Mouse Specificity: Imiquimod is human/mouse TLR7 agonist Stimulation of TLR7 can be achieved with 5-10μg/mL Recommended Storage Store at 4°C short term
- Aliquot and store at -20°C long term
- Avoid freeze-thaw cycles.
Compare Similar Items
Show Difference
Content And Storage: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For Use With (Application): For activation of TLR7
Product Type: Imiquimod, TLR7 Ligand
Quantity: 1 mg
Content And Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For Use With (Application):
For activation of TLR7
Product Type:
Imiquimod, TLR7 Ligand
Quantity:
1 mg
Content And Storage: Store at -20°C.
For Use With (Application): Identity determined by MS, 1H-NMR and 13C-NMR. This product is useful for activation of mouse TLR7 and human TLR7 and TLR8. Stimulation of TLR8 has been achieved with 0.5-5 ug/mL. Use in functional assays reported in scientific literature (PMID 26134251).
Product Type: Imidazoquinoline Resiquimod (R-848), TLR7 and TLR8 Ligand
Quantity: 0.5 mg
Content And Storage:
Store at -20°C.
For Use With (Application):
Identity determined by MS, 1H-NMR and 13C-NMR. This product is useful for activation of mouse TLR7 and human TLR7 and TLR8. Stimulation of TLR8 has been achieved with 0.5-5 ug/mL. Use in functional assays reported in scientific literature (PMID 26134251).
Product Type:
Imidazoquinoline Resiquimod (R-848), TLR7 and TLR8 Ligand
Quantity:
0.5 mg
Content And Storage: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For Use With (Application): Activation of human TLR9
Product Type: __
Quantity: 2 Vials
Content And Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
For Use With (Application):
Activation of human TLR9
Product Type:
__
Quantity:
2 Vials
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
For Use With (Application): This product is useful for activation of Toll-like Receptor 2 (TLR2). Stimulation of TLR2 has been reported with 1 to 10μL. Note: TLR2 activation at this range of concentrations of Zymosan has also been observed in our product validation tests. Use in In vivo assay and functional inhibition reported in scientific literature (PMID 25846753). Use in ligand activation reported in scientific literature (PMID 25957979). Use in in vitro reported in scientific literature (PMID 27351455).
Product Type: __
Quantity: 200 mg
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
For Use With (Application):
This product is useful for activation of Toll-like Receptor 2 (TLR2). Stimulation of TLR2 has been reported with 1 to 10μL. Note: TLR2 activation at this range of concentrations of Zymosan has also been observed in our product validation tests. Use in In vivo assay and functional inhibition reported in scientific literature (PMID 25846753). Use in ligand activation reported in scientific literature (PMID 25957979). Use in in vitro reported in scientific literature (PMID 27351455).
Product Type:
__
Quantity:
200 mg